Peer Review History
Original SubmissionJuly 2, 2021 |
---|
PONE-D-21-21682The two extremes of Hansen’s disease – Different manifestations of leprosy and their biological consequences in an Avar Age (late 7th century CE) osteoarchaeological series of the Duna-Tisza Interfluve (Kiskundorozsma–Daruhalom-dűlő II, Hungary)PLOS ONE Dear Dr. Spekker, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I now have two expert reviews of this work. Thank you for your patience as we worked to review your manuscript. Both reviewers felt there was merit in the work. There were suggestions for additional experimentation if possible as well as extensive edits. This is considered a major revision. Please submit your revised manuscript by Nov 13 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, JJ Cray Jr., Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. In your manuscript, please provide additional information regarding the specimens used in your study. Ensure that you have reported specimen numbers and complete repository information, including museum name and geographic location. If permits were required, please ensure that you have provided details for all permits that were obtained, including the full name of the issuing authority, and add the following statement: 'All necessary permits were obtained for the described study, which complied with all relevant regulations.' If no permits were required, please include the following statement: 'No permits were required for the described study, which complied with all relevant regulations.' For more information on PLOS ONE's requirements for paleontology and archaeology research, see https://journals.plos.org/plosone/s/submission-guidelines#loc-paleontology-and-archaeology-research. 3. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option. 4. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ 5. We note that Figures 2 - 11 in your submission contain copyrighted images. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: a. You may seek permission from the original copyright holder of Figures 2 - 11 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is an interesting article that provides very useful information on the extreme/polar clinical manifestations (lepromatous leprosy and tuberculoid leprosy) of Hansen disease in skeletal samples and the corresponding biological consequences observed in two individuals from the 7th century-CE cemetery of Kiskundorozsma–Daruhalom-dűlő II, Hungary. The paleopathological analysis of both individuals was complemented by ancient DNA analysis (previously published), where one sample yielded a possible DNA-positive for Mycobacterium leprae. Below, I provide my questions or recommendations for the authors: 1) I suggest choosing a single nomenclature for the disease, either Hansen disease or leprosy (or explain why using both terminologies). For example, in Results, the authors use HD (main text) but in most figure legends they use leprosy. If historical context is no needed or necessary, I prefer Hansen disease or (if the authors agree or if necessary) the more “neutral” term mycobacterial neurodermatosis. 2) I do not understand why the authors selected to include in Discussion a long general introduction of each category of the pathognomonic bone changes (bony changes of the skull; postcranial skeleton; leprosy-specific boney changes, and non-specific bony changes…). Yes, I agree that all this introductory information is important and useful (and the authors did an excellent summary for all of them), but most general information should be in the Introduction of the article, not the Discussion. The Discussion should be based mostly on the findings/conclusions observed on the two individuals (KD217 and KD520). I agree on adding (or repeating) in Discussion some useful osteological information to give context to the findings in this report. The authors could keep same subtitles in Discussion (Bony changes of the Skull; Bony changes of the postcranial skeleton…) but the text should be mainly focused on the Results; if the authors agree, the long introductory sections (most of the text/description) for bony changes could fit better in the Introduction. As mentioned before, following the title "The two extremes of Hansen's disease...", the authors should leave or bring some general osteological information to explain or justify why KD217 could be associated with LL, and KD520 with TL (i.e., as described for KD271, on page 20, ln 481-482, the perforation of the hard palate is a late phenomenon of LL) 3) I consider important the recognition of TL in skeletal samples (as done by V. Matos and other colleagues), and the authors (sorry if I am confused) initially presented in the Discussion that the evidence for concentric diaphyseal atrophy (right foot) is crucial to associate KD520 with TL, but at the end (pg. 35, ln 847-848) the authors cautiously wrote that “…as in KD520, other aetiologies should also be considered in the differential diagnosis”. Do the authors conclude that KD520 could be associated with TL because not only concentric diaphyseal atrophy was observed but inflammatory lesions (bilateral) on tibial nerve as well? If my observation is correct, I recommend expanding on that (if not, it looks that the TL diagnose for KD520 is weak or not definitive) The article is clear and well written, and I do celebrate new studies on Hansen disease in ancient skeletal samples that attempt to recognize osteological differences between LL and TL polar states. My recommendation is that the article should undergo minor revisions before final approval/acceptance. Reviewer #2: Dear authors, This manuscript presents two interesting paleopathological case studies from an Hungarian archaeological context from 7th century AD. GENERAL COMMENTS: The diagnosis of lepromatous leprosy for individuals KD271 is very convincing. Moreover, this diagnosis is supported by previously published paleomicrobiological analysis. The diagnosis of tuberculoid leprosy in skeleton KD520 is, in my opinion, more complex. I think it would have been useful to present any DNA results that might already exist for this skeleton. It is suggested to clarify this. Was skeleton KD520 tested for aDNA of M. leprae? If yes, what were the results? KEYWORDS: - please consider replacing “type” by “leprosy” (eg. tuberculoid leprosy) ABSTRACT: - add Hungary (l. 29) - add the total number of skeletons (n=94) from this archaeological series INTRODUCTION: - the text between lines 57-73 is really useful for the paper purposes? please consider removing it - please check the spelling of “achro-osteolysis”. Is it “acro-osteolysis”? (line 129 and bellow) - please consider replacing: “hand and/or foot bones” by “hand and/or foot phalanges, metacarpals and metatarsals” (line 130) - Objectives are clear and relevant. M&M: - please add the specific methods used to estimate sex and age at death of skeletons KD271 and KD520. It is unclear how these parameters were estimated for these individuals. (lines 247-250) - It is recommended adding the overall age and sex profiles of the skeletal series, if possible RESULTS: - the two cases are described in detail and bony lesions are very well described and shown in the figures. - It is suggested to add a photo (to be included in Fig. 4) showing the nasal surface of the palatine process of sk. 271. - please add the dimensions of the perforation of the palatine process (line 273) - please consider replacing: “tarsal bones of the feet” by “tarsal bones” (line 307) DISCUSSION: - This section is, in my opinion, very extensive and needs improvements including text reduction. - Please consider removing the following text: lines 416-453, 543-574, 625-690, 771-808. These parts are not properly discussion and are not necessary to discuss the two - cases. - it is suggested removing the word “pathognomonic” in line 404 - please consider deleting “of the face” in line 456 - it is suggested to avoid the term periostitis. Alternative: periosteal new bone - about osteoporosis (line 859): what methods were applied to evaluate osteoporosis? this is unclear and needs clarification - The discussion of the “Non-specific bony changes…” was made by dividing in three parts: motor, sensory, and autonomic peripheral neuropathy. I’m not sure if this “classic” artificial division, influenced by the radiological literature, is the most useful one. The authors are invited to rethink the organization and text reduction of this part of the discussion. Best reagrds. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
PONE-D-21-21682R1 The two extremes of Hansen’s disease – Different manifestations of leprosy and their biological consequences in an Avar Age (late 7th century CE) osteoarchaeological series of the Duna-Tisza Interfluve (Kiskundorozsma–Daruhalom-dűlő II, Hungary) Dr. Olga Spekker Dear Dr. Spekker, Thank you for reaching out and bringing this issue to our attention. In response to your request, we will reinstate your submission and resume the evaluation of your work, taking into account your response to the original concerns raised. I hope that I can help explain the current status of your manuscript. Firstly, accept my apologies for the error that occurred with your manuscript. Please know that there was nothing that the authors had done to cause your paper to be withdrawn, and this was an error on behalf of the journal. Your manuscript was unfortunately misattributed as resubmission to a different manuscript, and therefore, your paper was withdrawn in error. The manuscript has been returned to the 'Submissions Needing Revision' folder in your Editorial Manager account. If you would like to incorporate any changes to the manuscript in response to the original evaluation, please complete your revisions and resubmit your manuscript files. Your resubmission is due on Dec 25 2021 11:59PM. The manuscript will undergo another editorial evaluation, which may involve further external review at the editors' discretion, we thus cannot anticipate the outcome of this review process. Please note that the editorial decision reached following consideration final but you will have the opportunity to revise or resubmit if you wish. Please do not hesitate to contact us at plosone@plos.org if you have any queries regarding the appeal process. With best wishes, Alexis Miller Staff PLOS ONE |
Revision 2 |
PONE-D-21-21682R2The two extremes of Hansen’s disease – Different manifestations of leprosy and their biological consequences in an Avar Age (late 7th century CE) osteoarchaeological series of the Duna-Tisza Interfluve (Kiskundorozsma–Daruhalom-dűlő II, Hungary)PLOS ONE Dear Dr. Spekker, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. There are some additional details and edits that should be able to be accomplished in a minor revision. Note only an editorial desk review will be conducted upon resubmission. Please submit your revised manuscript by Apr 02 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, JJ Cray Jr., Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: I Don't Know Reviewer #4: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: No Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: I was not an original reviewer of the manuscript but I have read through the authors’ responses to the previous comments, which seem reasonable (though I should note too that I am not a specialist in paleopathology). With that said, I do not see any reason to not use the term “leprosy”, which is commonly used in both scientific and laymen’s literature. While there may be a certain stigma attached to the term, it should not preclude its use in cases such as this. I had a few other comments that I hope can help improve the paper, but will leave it to the previous reviewers to assess the quality of responses to revisions made. Overall, the paper requires some editing and wordsmithing. For example, the sentence on lines 34-36 would be better written as: “The led to severe deformation and disfigurement of the involved anatomical areas of the skeleton, resulting in the inability to perform the basic…..”. There are quite a few places through the ms where things could be stated more simply. The authors also use the “hook” of stating that the cases they report are: (lines 42-43) “amongst the very few published cases with leprosy from the Avar Age of the Hungarian Duna-Tisza Interfluve” (which is repeated a number of times in the paper). I’m sure this is the case, but it seems overly narrow to me. Without knowing much about the temporal range or geographical location of the specimens, it doesn’t seem that significant to me. Could the authors qualify this? Does this represent a period of centuries across a wide geographical area that was known to have significant outbreaks of leprosy but these are really the few that are known? If the chronological range and geographical area is narrow and limited, this statement just doesn’t seem that important on a global scale. Lines 50 – better to say “infectious disease found mainly in humans”. With that said, I’m curious, is it also transmissible among other primates? Line 56 – delete “of” before “caused” Line 72 – replace “hardly” with “minimally” P. 6 – I appreciate the historical background provided, but it would be helpful to provide a few more details about the transmission of leprosy to some other parts of the world to show just how pervasive, transmissible, and fearful it was to humans. A recent paper by Nelson et al. (2022) describe what is purported to be the earliest directly dated case in the Americas. There is also early evidence for the spread of leprosy to India (ca. 4000 BP) (see Robbins et al. 2009, 2013). These are just a few, but there are others that would be worth noting. In addition, given some misunderstandings about leprosy and how it could be contracted, as well as the desire to help those afflicted, there were many leprosaria established in remote or protected areas (individual islands in the Caribbean and Pacific are well-known examples) to sequester and render aid. Line 215 – replace “of” with “in biological anthropology” Lines 217-218 – use semicolons to separate sequentially numbered orders Line 360 – typo - should be “With” (not “Whit”) Line 636 – consider revising to: “It is important to note that apart from HD….” Line 639 and in several places after (e.g., Lines 670-674). There are a number of cases where longer or multiple sentences are in parentheses. These should usually be reserved for shorter explanations, so consider incorporating these into the text without parentheses. Line 674 – replace “decided” with “determined” Line 699 – remove double parentheses; instead, parentheses within parentheses should be changed to brackets (e.g., “….arthritis [RA] and psoriatic arthritis [PsA]) Line 738 – this is not an adage exclusive of aDNA, but is a commonly used phrase in science and beyond Line 745 – better to say “….in standing and walking and various physical actitivies.” Figure 1 is insufficient for an international audience. It is unclear where this region is located on a regional or global map. Please include one that shows where “A” is found. Map also needs a scale and north arrow. Figures 2 and others – remove parentheses after letter, which is unnecessary References Nelson, G.C., Dodrill, T.N. and Fitzpatrick, S.M., 2022. A probable case of leprosy from colonial period St. Vincent and the Grenadines, Southeastern Caribbean. International Journal of Paleopathology, 36, pp.7-13. Robbins, G., Tripathy, V.M., Misra, V.N., Mohanty, R.K., Shinde, V.S., Gray, K.M. and Schug, M.D., 2009. Ancient skeletal evidence for leprosy in India (2000 BC). PloS one, 4(5), p.e5669. Robbins Schug, G., Blevins, K.E., Cox, B., Gray, K. and Mushrif-Tripathy, V., 2013. Infection, disease, and biosocial processes at the end of the Indus Civilization. PLoS One, 8(12), p.e84814. Reviewer #4: My only comments are minor. They pertain to English and anatomical nomenclature. In the line 185"prevention" should be "salvage". In lines 275, 288 and 290 the term "turbinate" is used incorrectly. In humans the inferior concha is a separate bone, different from animal "turbinate" bones. A basic anatomical terminology error. Use inferior nasal concha. In the era of electronic (digital, on-line) publications, the use of abbreviations/acronyms saving the cost of printing ink and paper for numerous copies of printed papers saves nothig while it appears to be pretentiously "scientific" and makes reading of manuscripts difficult. I recommend to use full terms instead of pretentious acronymes like TT, LL, HD etc. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #3: No Reviewer #4: Yes: Emeritus Professor Maciej Henneberg [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 3 |
The two extremes of Hansen’s disease – Different manifestations of leprosy and their biological consequences in an Avar Age (late 7th century CE) osteoarchaeological series of the Duna-Tisza Interfluve (Kiskundorozsma–Daruhalom-dűlő II, Hungary) PONE-D-21-21682R3 Dear Dr. Spekker, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, JJ Cray Jr., Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-21-21682R3 The two extremes of Hansen’s disease – Different manifestations of leprosy and their biological consequences in an Avar Age (late 7th century CE) osteoarchaeological series of the Duna-Tisza Interfluve (Kiskundorozsma–Daruhalom-dűlő II, Hungary) Dear Dr. Spekker: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. JJ Cray Jr. Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .